| Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections SH MacVane Journal of intensive care medicine 32 (1), 25-37, 2017 | 249 | 2017 |
| Impact of extended‐spectrum â‐lactamase–producing organisms on clinical and economic outcomes in patients with urinary tract infection SH MacVane, LO Tuttle, DP Nicolau Journal of hospital medicine 9 (4), 232-238, 2014 | 152 | 2014 |
| Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program SH MacVane, FS Nolte Journal of clinical microbiology 54 (10), 2455-2463, 2016 | 151 | 2016 |
| Prolonging â-lactam infusion: a review of the rationale and evidence, and guidance for implementation SH MacVane, JL Kuti, DP Nicolau International journal of antimicrobial agents 43 (2), 105-113, 2014 | 101 | 2014 |
| Emergence of ceftolozane-tazobactam-resistant Pseudomonas aeruginosa during treatment is mediated by a single AmpC structural mutation SH MacVane, R Pandey, LL Steed, BN Kreiswirth, L Chen Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 01183-17, 2017 | 88 | 2017 |
| Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumonia SH MacVane, JL Kuti, DP Nicolau Antimicrobial agents and chemotherapy 58 (3), 1359-1364, 2014 | 87 | 2014 |
| Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections TV Magee, MF Brown, JT Starr, DC Ackley, JA Abramite, J Aubrecht, ... Journal of Medicinal Chemistry 56 (12), 5079-5093, 2013 | 70 | 2013 |
| Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes NJ Rhodes, SH MacVane, JL Kuti, MH Scheetz Clinical infectious diseases 59 (6), 905-907, 2014 | 54 | 2014 |
| Intravenous‐only or intravenous transitioned to oral antimicrobials for Enterobacteriaceae‐associated bacteremic urinary tract infection KL Rieger, JA Bosso, SH MacVane, Z Temple, A Wahlquist, N Bohm Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (11 …, 2017 | 46 | 2017 |
| In Vivo Efficacy of Humanized Exposures of Ceftazidime-Avibactam in Comparison with Ceftazidime against Contemporary Enterobacteriaceae Isolates SH MacVane, JL Crandon, WW Nichols, DP Nicolau Antimicrobial agents and chemotherapy 58 (11), 6913-6919, 2014 | 44 | 2014 |
| Unexpected In Vivo Activity of Ceftazidime Alone and in Combination with Avibactam against New Delhi Metallo-â-Lactamase-Producing Enterobacteriaceae in a … SH MacVane, JL Crandon, WW Nichols, DP Nicolau Antimicrobial Agents and Chemotherapy 58 (11), 7007-7009, 2014 | 39 | 2014 |
| Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia SH MacVane, JM Hurst, MS Boger, JW Gnann Jr Infectious Diseases 48 (10), 732-737, 2016 | 36 | 2016 |
| Implementation and optimization of molecular rapid diagnostic tests for bloodstream infections E Wenzler, TT Timbrook, JR Wong, JM Hurst, SH MacVane The Bulletin of the American Society of Hospital Pharmacists 75 (16), 1191-1202, 2018 | 30 | 2018 |
| Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae BA Santevecchi, TT Smith, SH MacVane International journal of antimicrobial agents 51 (4), 629-635, 2018 | 29 | 2018 |
| Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype M Castanheira, SJR Arends, AP Davis, LN Woosley, AA Bhalodi, ... Msphere 3 (5), 10.1128/msphere. 00408-18, 2018 | 28 | 2018 |
| Demography and burden of care associated with patients readmitted for urinary tract infection SH MacVane, LO Tuttle, DP Nicolau Journal of Microbiology, Immunology and Infection 48 (5), 517-524, 2015 | 28 | 2015 |
| The role of antimicrobial stewardship in the clinical microbiology laboratory: stepping up to the plate SH MacVane, JM Hurst, LL Steed Open forum infectious diseases 3 (4), ofw201, 2016 | 24 | 2016 |
| Clinical laboratory–based assay methodologies may underestimate and increase variability of vancomycin protein binding in hospitalized patients JL Crandon, SH MacVane, DP Nicolau Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (2 …, 2014 | 24 | 2014 |
| Characterizing In Vivo Pharmacodynamics of Carbapenems against Acinetobacter baumannii in a Murine Thigh Infection Model To Support Breakpoint … SH MacVane, JL Crandon, DP Nicolau Antimicrobial agents and chemotherapy 58 (1), 599-601, 2014 | 22 | 2014 |
| Incidence and risk factors for development of thrombocytopenia in patients treated with linezolid for 7 days or greater AD Rabon, JP Fisher, SH MacVane Annals of Pharmacotherapy 52 (11), 1162-1164, 2018 | 19 | 2018 |
